Dare Bioscience Inc. (DARE)
Market Closed
12 Dec, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XBER $
2. 46
+0.37
+17.7%
$
17.23M Market Cap
- P/E Ratio
0% Div Yield
2,154,336 Volume
-0.25 Eps
$ 2.09
Previous Close Day Range
2.17 2.52
Year Range
1.61 9.19
Want to track DARE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Daré Bioscience, Inc. (DARE) Q2 2024 Earnings Call Transcript
Daré Bioscience, Inc. (NASDAQ:DARE ) Q2 2024 Earnings Call Transcript August 12, 2024 4:30 PM ET Company Participants MarDee Haring-Layton - CAO Sabrina Martucci Johnson - President and CEO Conference Call Participants Catherine Novack - Jones Research Douglas Tsao - H.C. Wainwright & Co. Operator Welcome to the conference call hosted by Daré Bioscience to review the company's second quarter financial results and to provide a general business update.
Seekingalpha | 1 year ago
Dare Bioscience, Inc. (DARE) Q2 Earnings Top Estimates
Dare Bioscience, Inc. (DARE) came out with quarterly earnings of $1.52 per share, beating the Zacks Consensus Estimate of a loss of $0.57 per share. This compares to loss of $1.20 per share a year ago.
Zacks | 1 year ago
2025 © Marketlog. All Rights Reserved.
